Aspect Imaging Unveils Soft Tissue Contrast Capabilities For Its Compact MRI To Increase Optical Imaging Efficiency

Published on:

TEL-AVIV, Israel--Aspect Imaging (http://www.aspectimaging.com/), a developer of compact high-performance MRI systems, is introducing a new Fluorescent Imaging Tomography (FLIT) combined with MRI Compact system, “FLIT-MRI system,” to enhance optical imaging in MRIs for soft tissue in small animal research. Aspect Imaging’s user friendly, compact and efficient system enables the FLIT optical research community to fuse optical data with advanced soft tissue image quality.

Aspect Imaging is offering a cost-effective package for its Flit-MRI system, as part of a complementary and expanding suite of preclinical multi-modality imaging systems, including the VivoFuseTM 3D Optical BLI and MRI Fusion system for $323,000; and the SimPETTM Simultaneous Pet/MRI system for $699,000. Aspect Imaging is also offering to upgrade existing 7T or 9.4T MRI systems to PET/MRI with its new PET insert for $349,000.

“We’re thrilled to be able to provide the tools to effectively analyze MRI results with clear soft tissue images, said Uri Rapoport, CEO and Founder of Aspect Imaging. With our cost effective MRI packages, we strive to make our advanced technology systems more accessible to the preclinical research community.”

You can learn more about Aspect Imaging MRI systems here: http://www.aspect-preclinical.com/

Aspect Imaging is showcasing its technology at World Molecular Imaging Congress (WMIC) in Philadelphia on September 13-16, Booth #500.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.